Flamel Technologies S.A. (FLML) 15.84 $FLML
Flamel Technologies S.A. - Product Pipeline Review - 2014
M2 - Mon Apr 20, 4:03AM CDT
Product Pipeline Review - 2014
FLML: 15.84 (-0.33)
Affimed N.V. (AFMD) Shows Strength: Stock Moves Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 7:51AM CDT
Affimed N.V. (AFMD) was a big mover last session, as its shares rose over 15% on the day.
FLML: 15.84 (-0.33), AFMD: 7.94 (+0.11)
Ocular Therapeutix (OCUL) in Focus: Stock Goes Down 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 7:31AM CDT
Ocular Therapeutix (OCUL) fell over 6% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 29% in the past one month.
FLML: 15.84 (-0.33), OCUL: 25.90 (-0.05)
Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 09, 5:15PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
GEOS: 20.76 (+0.57), FLML: 15.84 (-0.33), RECN: 16.46 (+0.14), SEV: 7.27 (-0.02), QURE: 26.15 (-1.44), FONR: 11.72 (+0.08), MARPS: 12.39 (+0.21), ANGI: 6.46 (+0.31), AKAO: 6.21 (-0.50), OCUL: 25.90 (-0.05), AREX: 8.15 (-0.30)
Corcept Therapeutics (CORT) Looks Good: Stock Up 83.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 7:51AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose roughly 29% on the day.
FLML: 15.84 (-0.33), CORT: 6.44 (+0.38)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 11:46AM CDT
CEQP: 6.73 (+0.09), SBSA: 5.74 (-0.13), PRGO: 201.50 (+8.68), YUMA: 0.93 (-0.03), QKLS: 2.33 (-0.21), BALT: 1.61 (+0.08), SYRX: 2.09 (-0.05), TEDU: 12.70 (-0.26), NADL: 1.51 (+0.01), DSKY: 10.00 (+0.26), YZC: 10.32 (+0.10), AMCN: 4.43 (+0.44), CNYD: 2.41 (-0.09), FLML: 15.84 (-0.33), NURO: 1.32 (-0.02), PQ: 2.54 (+0.02), PSTR: 4.78 (+0.07), CHNR: 2.24 (+0.05), CAPN: 6.99 (-0.29), KONE: 4.78 (-0.29)
5.3% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Apr 08, 9:24AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on March 10th, 2015 at $16.29. In approximately 4 weeks, Flamel Technologies has returned 5.28% as of today's recent price of $17.15.
FLML: 15.84 (-0.33)
Flamel Technologies Announces Departure of Senior Vice President of Business and Corporate Development
Marketwired - Tue Apr 07, 5:05PM CDT
Flamel Technologies S.A. (NASDAQ: FLML) today announced that Steve Lisi, the Senior Vice President of Business and Corporate Development at Flamel, has left the Company for personal reasons.
FLML: 15.84 (-0.33)
Egalet (EGLT) in Focus: Stock Plunges 11.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 7:36AM CDT
Shares of Egalet (EGLT) fell by nearly 12 % on the day. This continues the recent trend for EGLT as the stock is now down nearly 27% since Mar 19. So make sure to keep an eye on this stock going forward to see if this recent slump will continue.
EGLT: 10.34 (-0.27), FLML: 15.84 (-0.33)
ImmunoGen (IMGN) in Focus: Stock Rises 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 7:37AM CDT
ImmunoGen, Inc. (IMGN) was a big mover last session, as the company saw its shares rise more than 5% on the day.
FLML: 15.84 (-0.33), IMGN: 9.96 (+0.01)
Rigel Pharmaceuticals (RIGL) Looks Good: Stock Up 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 7:30AM CDT
Rigel Pharmaceuticals, Inc. (RIGL) was a big mover last session, as the company saw its shares rise roughly 7% on the day.
FLML: 15.84 (-0.33), RIGL: 4.24 (+0.07)
Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With LiquiTime(R) Guaifenesin
Marketwired - Fri Mar 27, 7:30AM CDT
Flamel Technologies (NASDAQ: FLML) today announced the results of a First-in-Man (FIM) clinical study in healthy volunteers using its proprietary LiquiTime(R) drug delivery platform applied to guaifenesin, a broadly used expectorant. LiquiTime is designed to provide a controlled, extended release of oral liquids principally for pediatric and geriatric patients.
FLML: 15.84 (-0.33)
United Therapeutics (UTHR) Crumbles: Stock Falls by 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 7:48AM CDT
United Therapeutics' shares fell by nearly 7% on the day reversing the uptrend
FLML: 15.84 (-0.33), UTHR: 187.98 (+0.12)
Falling Earnings Estimates Signal Weakness Ahead for WuXi PharmaTech (WX) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 23, 7:47AM CDT
WuXi PharmaTech has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
FLML: 15.84 (-0.33), WX: 39.15 (-0.60)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
EVOL: 9.42 (-0.19), FLML: 15.84 (-0.33), EARS: 4.65 (-0.75), FICO: 92.00 (-0.15), CTRN: 24.27 (+0.16)
Flamel Technologies posts higher net loss of USD84.9m in 2014
M2 - Fri Mar 20, 5:44AM CDT
Drug delivery company Flamel Technologies (NASDAQ:FLML) stated on Thursday that it recorded a net loss of USD84.9m (loss per share of 2.34, basic and diluted) for the fiscal year 2014.
FLML: 15.84 (-0.33)
Flamel's (FLML) CEO Mike Anderson on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 19, 1:04PM CDT
FLML: 15.84 (-0.33)
Flamel Technologies Q4 and FY14 results
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 7:23AM CDT
FLML: 15.84 (-0.33)
Flamel Technologies beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 7:07AM CDT
FLML: 15.84 (-0.33)
Flamel Technologies S.A. - Product Pipeline Review - 2014
M2 - Mon Apr 20, 4:03AM CDT
Product Pipeline Review - 2014
FLML: 15.84 (-0.33)
Affimed N.V. (AFMD) Shows Strength: Stock Moves Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 7:51AM CDT
Affimed N.V. (AFMD) was a big mover last session, as its shares rose over 15% on the day.
FLML: 15.84 (-0.33), AFMD: 7.94 (+0.11)
Ocular Therapeutix (OCUL) in Focus: Stock Goes Down 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 7:31AM CDT
Ocular Therapeutix (OCUL) fell over 6% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 29% in the past one month.
FLML: 15.84 (-0.33), OCUL: 25.90 (-0.05)
Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 09, 5:15PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
GEOS: 20.76 (+0.57), FLML: 15.84 (-0.33), RECN: 16.46 (+0.14), SEV: 7.27 (-0.02), QURE: 26.15 (-1.44), FONR: 11.72 (+0.08), MARPS: 12.39 (+0.21), ANGI: 6.46 (+0.31), AKAO: 6.21 (-0.50), OCUL: 25.90 (-0.05), AREX: 8.15 (-0.30)
Corcept Therapeutics (CORT) Looks Good: Stock Up 83.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 7:51AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose roughly 29% on the day.
FLML: 15.84 (-0.33), CORT: 6.44 (+0.38)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 11:46AM CDT
CEQP: 6.73 (+0.09), SBSA: 5.74 (-0.13), PRGO: 201.50 (+8.68), YUMA: 0.93 (-0.03), QKLS: 2.33 (-0.21), BALT: 1.61 (+0.08), SYRX: 2.09 (-0.05), TEDU: 12.70 (-0.26), NADL: 1.51 (+0.01), DSKY: 10.00 (+0.26), YZC: 10.32 (+0.10), AMCN: 4.43 (+0.44), CNYD: 2.41 (-0.09), FLML: 15.84 (-0.33), NURO: 1.32 (-0.02), PQ: 2.54 (+0.02), PSTR: 4.78 (+0.07), CHNR: 2.24 (+0.05), CAPN: 6.99 (-0.29), KONE: 4.78 (-0.29)
5.3% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Apr 08, 9:24AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on March 10th, 2015 at $16.29. In approximately 4 weeks, Flamel Technologies has returned 5.28% as of today's recent price of $17.15.
FLML: 15.84 (-0.33)
Flamel Technologies Announces Departure of Senior Vice President of Business and Corporate Development
Marketwired - Tue Apr 07, 5:05PM CDT
Flamel Technologies S.A. (NASDAQ: FLML) today announced that Steve Lisi, the Senior Vice President of Business and Corporate Development at Flamel, has left the Company for personal reasons.
FLML: 15.84 (-0.33)
Egalet (EGLT) in Focus: Stock Plunges 11.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 7:36AM CDT
Shares of Egalet (EGLT) fell by nearly 12 % on the day. This continues the recent trend for EGLT as the stock is now down nearly 27% since Mar 19. So make sure to keep an eye on this stock going forward to see if this recent slump will continue.
EGLT: 10.34 (-0.27), FLML: 15.84 (-0.33)
ImmunoGen (IMGN) in Focus: Stock Rises 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 7:37AM CDT
ImmunoGen, Inc. (IMGN) was a big mover last session, as the company saw its shares rise more than 5% on the day.
FLML: 15.84 (-0.33), IMGN: 9.96 (+0.01)
Rigel Pharmaceuticals (RIGL) Looks Good: Stock Up 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 7:30AM CDT
Rigel Pharmaceuticals, Inc. (RIGL) was a big mover last session, as the company saw its shares rise roughly 7% on the day.
FLML: 15.84 (-0.33), RIGL: 4.24 (+0.07)
Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With LiquiTime(R) Guaifenesin
Marketwired - Fri Mar 27, 7:30AM CDT
Flamel Technologies (NASDAQ: FLML) today announced the results of a First-in-Man (FIM) clinical study in healthy volunteers using its proprietary LiquiTime(R) drug delivery platform applied to guaifenesin, a broadly used expectorant. LiquiTime is designed to provide a controlled, extended release of oral liquids principally for pediatric and geriatric patients.
FLML: 15.84 (-0.33)
United Therapeutics (UTHR) Crumbles: Stock Falls by 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 7:48AM CDT
United Therapeutics' shares fell by nearly 7% on the day reversing the uptrend
FLML: 15.84 (-0.33), UTHR: 187.98 (+0.12)
Falling Earnings Estimates Signal Weakness Ahead for WuXi PharmaTech (WX) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 23, 7:47AM CDT
WuXi PharmaTech has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
FLML: 15.84 (-0.33), WX: 39.15 (-0.60)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
EVOL: 9.42 (-0.19), FLML: 15.84 (-0.33), EARS: 4.65 (-0.75), FICO: 92.00 (-0.15), CTRN: 24.27 (+0.16)
Flamel Technologies posts higher net loss of USD84.9m in 2014
M2 - Fri Mar 20, 5:44AM CDT
Drug delivery company Flamel Technologies (NASDAQ:FLML) stated on Thursday that it recorded a net loss of USD84.9m (loss per share of 2.34, basic and diluted) for the fiscal year 2014.
FLML: 15.84 (-0.33)
Flamel's (FLML) CEO Mike Anderson on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 19, 1:04PM CDT
FLML: 15.84 (-0.33)
Flamel Technologies Q4 and FY14 results
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 7:23AM CDT
FLML: 15.84 (-0.33)
Flamel Technologies beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 7:07AM CDT
FLML: 15.84 (-0.33)
